{"id":256322,"date":"2026-08-19T23:30:22","date_gmt":"2026-08-19T23:30:22","guid":{"rendered":"https:\/\/www.europesays.com\/ee\/256322\/"},"modified":"2026-08-19T23:30:22","modified_gmt":"2026-08-19T23:30:22","slug":"moderna-aktsia-soostis-vahivaktsiini-edu-jarel-105-protsenti","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ee\/256322\/","title":{"rendered":"Moderna aktsia s\u00f6\u00f6stis v\u00e4hivaktsiini edu j\u00e4rel 105 protsenti"},"content":{"rendered":"<p>Moderna ja Mercki eksperimentaalne v\u00e4hivaktsiin on andnud esimese julgustava s\u00f5numi melanoomihaigetele: hilises staadiumis tehtud uuringus n\u00e4hti esialgseid positiivseid tulemusi. Iga patsiendi kasvaja j\u00e4rgi kohandatud mRNA-p\u00f5hine s\u00fcst lubab suunata immuuns\u00fcsteemi r\u00fcndama just neid rakke, millest kasvaja alguse on saanud.<\/p>\n<p>Teadlased r\u00e4\u00e4givad juba ajaloolisest hetkest melanoomi ravis, kuid tegu on alles \u00fche sammuga pikal teel. Mis eristab seda vaktsiini senistest raviv\u00f5tetest, kui kaugel ollakse tavapraktikast ja miks on see l\u00e4bimurre kriitilise t\u00e4htsusega ka Moderna tuleviku jaoks?<\/p>\n","protected":false},"excerpt":{"rendered":"Moderna ja Mercki eksperimentaalne v\u00e4hivaktsiin on andnud esimese julgustava s\u00f5numi melanoomihaigetele: hilises staadiumis tehtud uuringus n\u00e4hti esialgseid positiivseid&hellip;\n","protected":false},"author":2,"featured_media":256323,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[5],"tags":[68,26,27,37,33,35,67,34,36,31,32,21,63,66,28,29,64,19,25,69,62,23,24,65,22,20,30],"class_list":["post-256322","post","type-post","status-publish","format-standard","has-post-thumbnail","category-uldised-uudised","tag-bors","tag-breaking-news","tag-breakingnews","tag-ee","tag-eesti","tag-eesti-keel","tag-elustiil","tag-estonia","tag-estonian","tag-featured-news","tag-featurednews","tag-headlines","tag-investor","tag-juhtimine","tag-latest-news","tag-latestnews","tag-majandusuudised","tag-news","tag-populaarseimad-lood","tag-skp","tag-tarbija","tag-top-stories","tag-topstories","tag-turundus","tag-uldised-uudised","tag-uudised","tag-viimased-uudised"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ee\/117124780724328849","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/256322","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/comments?post=256322"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/256322\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media\/256323"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media?parent=256322"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/categories?post=256322"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/tags?post=256322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}